[Plsfaculty] FW: "How to Navigate the Biotech Regulatory Process" A Works hop and Networking Reception
Donna-Rae Marquez
dmarquez at ag.arizona.edu
Fri Sep 16 15:42:24 MST 2011
From: Printing & Publishing 3Ds [mailto:PPSS3DS at LISTSERV.ARIZONA.EDU] On
Behalf Of 3D Memo
Sent: Friday, September 16, 2011 3:37 PM
To: PPSS3DS at LISTSERV.ARIZONA.EDU
Subject: "How to Navigate the Biotech Regulatory Process" A Works hop and
Networking Reception
TO: The UA Research Community
FROM: Bruce Wright, Associate Vice President for University Research Parks
SUBJECT: "How to Navigate the Biotech Regulatory Process" A Workshop and
Networking Reception
Presented by the Office of University Research Parks and The Arizona Center
for Innovation
When: Tuesday, September 20, 2011
Workshop: 8:00 am - 4:15 pm
BIO-SA Reception: 4:30 - 6:00 pm
Where: Doubletree Reid Park
445 S. Alvernon Way, Tucson, AZ 85711
Cost: $25 (includes materials, lunch and reception)
Workshops Include:
- General overview of the FDA regulatory process
- Importance of your patient demographic market
- Learn how to best develop and implement an international strategy
for selling your device or drug outside the US
- Explore future trends in the development of new drugs and devices as
well as the regulatory process
Presenters:
Marlene Haffner, MD, MPH is the CEO of Haffner Associates, LLC., a firm
dedicated to the strategy, development and policy of drug development with a
special emphasis on rare diseases and the products that treat them. She
also spent more than 25 years working for the FDA as the Director of the
Office of Health Affairs in the CDRH, and Director of the Office of Orphan
Products Development
David Feigal, MD, MPH is a Partner NDA Partners. He held senior positions
in FDA medical product centers including the Center Director of CDRH, the
Deputy Center Director of CBER and Director of the Office of Drug Evaluation
IV (Anti-infective-Antiviral Drug Products), CDER.
Barbara Wuebbels, RN, MS -is the Manager of Medical Affairs Investigator
Relations for BioMarin Pharmaceutical located in Novato, CA. She has worked
in the orphan drug arena for the past 12 years. Prior to joining BioMarin,
she was Director at Ucycld Pharma a subsidiary of Medicis Pharmaceutical
Corp. She is actively involved with national and international rare disease
organizations and patient advocacy groups.
For more information:
<http://azinnovation.com/sites/default/files/FDA%20Workshop%20Flyer%20Final.
pdf>
http://azinnovation.com/sites/default/files/FDA%20Workshop%20Flyer%20Final.p
df
To register please contact Lori Kavanaugh at 520.382.3260 or
lkavanaugh at azinnovation.com
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://list.cals.arizona.edu/pipermail/plsfaculty/attachments/20110916/f263f7b8/attachment.htm>
More information about the Plsfaculty
mailing list